230 related articles for article (PubMed ID: 19796808)
1. Prediction of the solubility of cucurbitacin drugs in self-associating poly(ethylene oxide)-b-poly(alpha-benzyl carboxylate epsilon-caprolactone) block copolymer with different tacticities using molecular dynamics simulation.
Patel SK; Lavasanifar A; Choi P
Biomaterials; 2010 Jan; 31(2):345-57. PubMed ID: 19796808
[TBL] [Abstract][Full Text] [Related]
2. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
[TBL] [Abstract][Full Text] [Related]
3. Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic Cucurbitacin drugs.
Patel SK; Lavasanifar A; Choi P
Biomacromolecules; 2009 Sep; 10(9):2584-91. PubMed ID: 19655789
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics study of the encapsulation capability of a PCL-PEO based block copolymer for hydrophobic drugs with different spatial distributions of hydrogen bond donors and acceptors.
Patel SK; Lavasanifar A; Choi P
Biomaterials; 2010 Mar; 31(7):1780-6. PubMed ID: 19962756
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
[TBL] [Abstract][Full Text] [Related]
6. Application of molecular dynamics simulation to predict the compatability between water-insoluble drugs and self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymers.
Patel S; Lavasanifar A; Choi P
Biomacromolecules; 2008 Nov; 9(11):3014-23. PubMed ID: 18937398
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar.
Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A
Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
Safaei Nikouei N; Lavasanifar A
Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
[TBL] [Abstract][Full Text] [Related]
9. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics study of the diffusivity of a hydrophobic drug Cucurbitacin B in pseudo-poly(ethylene oxide-b-caprolactone) micelle environments.
Razavilar N; Choi P
Langmuir; 2014 Jul; 30(26):7798-803. PubMed ID: 24927468
[TBL] [Abstract][Full Text] [Related]
11. Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility.
Latere Dwan'Isa JP; Rouxhet L; Préat V; Brewster ME; Ariën A
Pharmazie; 2007 Jul; 62(7):499-504. PubMed ID: 17718189
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
13. N-heterocyclic carbene-induced zwitterionic ring-opening polymerization of ethylene oxide and direct synthesis of alpha,omega-difunctionalized poly(ethylene oxide)s and poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymers.
Raynaud J; Absalon C; Gnanou Y; Taton D
J Am Chem Soc; 2009 Mar; 131(9):3201-9. PubMed ID: 19209910
[TBL] [Abstract][Full Text] [Related]
14. Adsorption of poly(ethylene oxide)-b-poly(epsilon-caprolactone) copolymers at the silica-water interface.
Vangeyte P; Leyh B; Rojas OJ; Claesson PM; Heinrich M; Auvray L; Willet N; Jérôme R
Langmuir; 2005 Mar; 21(7):2930-40. PubMed ID: 15779968
[TBL] [Abstract][Full Text] [Related]
15. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
16. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
Azzam T; Eisenberg A
Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
[TBL] [Abstract][Full Text] [Related]
17. Controlled synthesis and interface properties of new amphiphilic PCL-g-PEO copolymers.
Rieger J; Dubois P; Jérôme R; Jérôme C
Langmuir; 2006 Aug; 22(18):7471-9. PubMed ID: 16922523
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
Garg SM; Vakili MR; Lavasanifar A
Colloids Surf B Biointerfaces; 2015 Aug; 132():161-70. PubMed ID: 26037706
[TBL] [Abstract][Full Text] [Related]
19. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
Shahin M; Ahmed S; Kaur K; Lavasanifar A
Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
[TBL] [Abstract][Full Text] [Related]
20. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
Shahin M; Lavasanifar A
Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
